Xtant Medical to Issue Third Quarter 2022 Financial Results on November 3, 2022
October 27 2022 - 8:00AM
Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global
medical technology company focused on surgical solutions for the
treatment of spinal disorders, today announced that it will release
its financial results for the third quarter ended September 30,
2022, before the open of the financial markets on Thursday,
November 3, 2022.
Sean Browne, President and Chief Executive
Officer, and Scott Neils, Chief Financial Officer, will host a
conference call on Thursday, November 3 at 9:00 AM ET to review
results.
Conference
DetailsConference Date: Thursday,
November 3, 2022 - 9:00 AM ETConference dial-in:
877-407-6184International dial-in:
201-389-0877Conference Call Name: Xtant Medical Q3
2022 Financial ResultsWebcast Registration: Click
Here
Following the live call, a replay will be
available on the Company’s website, www.xtantmedical.com, under
“Investor Info.”
About Xtant Medical Holdings,
Inc.
Xtant Medical Holdings, Inc.
(www.xtantmedical.com) is a global medical technology company
focused on the design, development, and commercialization of a
comprehensive portfolio of orthobiologics and spinal implant
systems to facilitate spinal fusion in complex spine, deformity and
degenerative procedures. Xtant people are dedicated and talented,
operating with the highest integrity to serve our customers.
The symbols ™ and ® denote trademarks and
registered trademarks of Xtant Medical Holdings, Inc. or its
affiliates, registered as indicated in the United States, and in
other countries. All other trademarks and trade names referred to
in this release are the property of their respective owners.
Investor Relations Contact
David CareyLazar FINN PartnersPh: 212-867-1762Email:
david.carey@finnpartners.com
Xtant Medical (AMEX:XTNT)
Historical Stock Chart
From Apr 2024 to May 2024
Xtant Medical (AMEX:XTNT)
Historical Stock Chart
From May 2023 to May 2024